{"id":"18f-fluoromethylcholine","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3707345","moleculeType":"Small molecule","molecularWeight":"135.19"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"18F-fluoromethylcholine is a radioligand used for positron emission tomography (PET) imaging of prostate cancer.","oneSentence":"PET imaging agent for prostate cancer","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:25:17.541Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prostate cancer"}]},"trialDetails":[{"nctId":"NCT07444723","phase":"PHASE2, PHASE3","title":"Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2026-04-01","conditions":"Primary Hyperparathyroidism, Parathyroid Cancer, Multiple Endocrine Neoplasias","enrollment":193},{"nctId":"NCT07218224","phase":"","title":"Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas","status":"AVAILABLE","sponsor":"Thomas Hope","startDate":"","conditions":"Parathyroid Adenomas","enrollment":""},{"nctId":"NCT05891769","phase":"PHASE2, PHASE3","title":"99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT","status":"RECRUITING","sponsor":"Andrei Iagaru","startDate":"2023-09-27","conditions":"Parathyroid Adenoma","enrollment":100},{"nctId":"NCT07138820","phase":"NA","title":"18F-choline Positron-emission-tomography - Computed-tomography Compared to Conventional Imaging for Localizing Diseased Parathyroid Glands in Primary Hyperparathyroidism","status":"RECRUITING","sponsor":"Region Skane","startDate":"2023-01-01","conditions":"Primary Hyperparathyroidism","enrollment":88},{"nctId":"NCT03891914","phase":"PHASE3","title":"Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2019-11-12","conditions":"Myeloma Multiple","enrollment":20},{"nctId":"NCT04965454","phase":"PHASE2","title":"Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"Queen's Medical Center","startDate":"2022-03-28","conditions":"Hepatocellular Carcinoma Non-resectable","enrollment":80},{"nctId":"NCT06835426","phase":"NA","title":"High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins","status":"RECRUITING","sponsor":"Algemeen Ziekenhuis Maria Middelares","startDate":"2023-08-06","conditions":"Breast Carcinoma, Prostate Cancer Surgery, Thyroid Cancer","enrollment":150},{"nctId":"NCT06242119","phase":"","title":"Clinical Application of the J-PET Scanner Prototype","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2024-03-07","conditions":"Prostate Cancer, Prostatic Hyperplasia, Prostatic Neoplasms","enrollment":25},{"nctId":"NCT06334965","phase":"NA","title":"Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-18","conditions":"Hepatocellular Carcinoma, Radioembolization","enrollment":180},{"nctId":"NCT04895631","phase":"PHASE3","title":"18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas","status":"RECRUITING","sponsor":"Thomas Hope","startDate":"2021-06-30","conditions":"Hyperparathyroidism, Primary","enrollment":140},{"nctId":"NCT05359939","phase":"NA","title":"A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2023-01-16","conditions":"Hepatocellular Carcinoma","enrollment":50},{"nctId":"NCT04316845","phase":"NA","title":"18F-fluorocholine PET/CT for Hyperparathyroidism","status":"COMPLETED","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2018-01-16","conditions":"Hyperparathyroidism","enrollment":38},{"nctId":"NCT05622162","phase":"PHASE3","title":"Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7","status":"ACTIVE_NOT_RECRUITING","sponsor":"ITEL Telecomunicazioni Srl","startDate":"2022-12-19","conditions":"Prostate Cancer, 18F- Fluorocholine, PSMA PET","enrollment":106},{"nctId":"NCT04150458","phase":"PHASE3","title":"Fluorocholine PET/CT Basket Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2022-11-30","conditions":"Fluorocholine PET/CT","enrollment":2000},{"nctId":"NCT04009174","phase":"NA","title":"Multi-modality Prostate Cancer Image Guided Interventions","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2012-02-12","conditions":"Prostate Cancer","enrollment":52},{"nctId":"NCT03324893","phase":"NA","title":"FCH PET/MRI Parathyroid Localization","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2018-04-03","conditions":"18F-fluorocholine, Positron-Emission Tomography, Hyperparathyroidism, Primary","enrollment":47},{"nctId":"NCT04391348","phase":"NA","title":"Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCC","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-07-17","conditions":"Hepatocellular Carcinoma","enrollment":230},{"nctId":"NCT02640313","phase":"PHASE3","title":"Molecular Imaging of Plaque Vulnerability","status":"UNKNOWN","sponsor":"Maastricht University Medical Center","startDate":"2015-12","conditions":"Plaque, Atherosclerotic","enrollment":14},{"nctId":"NCT04349358","phase":"NA","title":"FCH vs FDG PET/CT in Detection of Lesions in Patients With Multiple Myeloma (MIM)","status":"RECRUITING","sponsor":"Centre Georges Francois Leclerc","startDate":"2020-12-15","conditions":"Multiple Myeloma","enrollment":38},{"nctId":"NCT02847468","phase":"NA","title":"Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib","status":"TERMINATED","sponsor":"Centre Georges Francois Leclerc","startDate":"2017-03-27","conditions":"Carcinoma, Hepatocellular","enrollment":61},{"nctId":"NCT02037945","phase":"NA","title":"18F-Fluorocholine (18F-FCho) to Distinguish Necrosis From Recurrence in Brain Metastases","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2014-01","conditions":"Brain Metastases","enrollment":19},{"nctId":"NCT01310192","phase":"PHASE1","title":"Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography","status":"COMPLETED","sponsor":"Queen's Medical Center","startDate":"2004-06","conditions":"Prostate Cancer","enrollment":20},{"nctId":"NCT02815033","phase":"PHASE2","title":"Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide","status":"COMPLETED","sponsor":"The European Uro-Oncology Group","startDate":"2015-07","conditions":"Prostate Cancer Metastatic","enrollment":66},{"nctId":"NCT02131649","phase":"NA","title":"PET/MRI for Men Being Considered for Radiotherapy for Suspected Prostate Cancer Recurrence Post-Prostatectomy","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2015-02","conditions":"Prostate Cancer","enrollment":99},{"nctId":"NCT03764007","phase":"PHASE2, PHASE3","title":"18F-Fluorocholine for the Detection of Parathyroid Adenomas","status":"COMPLETED","sponsor":"Thomas Hope","startDate":"2016-09-21","conditions":"Hyperparathyroidism, Primary","enrollment":98},{"nctId":"NCT02397408","phase":"PHASE2","title":"11C- and 18F-Choline PET/MR Imaging for Prostate Cancer","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-04-09","conditions":"Prostate Cancer","enrollment":18},{"nctId":"NCT04626206","phase":"","title":"Multi -paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases","status":"UNKNOWN","sponsor":"Royal Marsden NHS Foundation Trust","startDate":"2020-12","conditions":"Brain Metastases, Adult","enrollment":12},{"nctId":"NCT03643055","phase":"","title":"18F-Fluorocholine PET/CT in Medullary Thyroid Cancer","status":"UNKNOWN","sponsor":"University Medical Centre Ljubljana","startDate":"2014-09-03","conditions":"Medullary Thyroid Cancer","enrollment":80},{"nctId":"NCT04570033","phase":"NA","title":"The Utility of 18F-fluorocholine PET/CT in the Imaging of Parathyroid Adenomas","status":"COMPLETED","sponsor":"Military Institute od Medicine National Research Institute","startDate":"2016-01-01","conditions":"Hyperparathyroidism, Parathyroid Adenoma","enrollment":65},{"nctId":"NCT04340765","phase":"NA","title":"18F-fluorocholine and 18F-fluoride PET in Prostate Cancer","status":"COMPLETED","sponsor":"Buddhist Tzu Chi General Hospital","startDate":"2018-02-01","conditions":"Prostate Cancer, Fluorocholine","enrollment":36},{"nctId":"NCT03252990","phase":"","title":"18F-fluorocholine PET-MR Imaging of Coronary Plaque Vulnerability","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2018-03-02","conditions":"Myocardial Infarction, Myocardial Ischemia, Atherosclerosis","enrollment":15},{"nctId":"NCT01751737","phase":"NA","title":"Choline PET/CT and MRI for Targeted Prostate Biopsy","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2012-11","conditions":"Prostate Cancer","enrollment":63},{"nctId":"NCT03555487","phase":"PHASE3","title":"Clinical Value of 18F-FCH PET in Localizing Parathyroid Lesions: Comparison With MIBI Scan.","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2015-05-05","conditions":"Parathyroid Diseases","enrollment":103},{"nctId":"NCT02121600","phase":"NA","title":"18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2014-09","conditions":"Prostate Cancer","enrollment":5},{"nctId":"NCT02784223","phase":"NA","title":"Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot Study","status":"COMPLETED","sponsor":"Centre Francois Baclesse","startDate":"2016-05","conditions":"Thyroid Gland","enrollment":107},{"nctId":"NCT01395030","phase":"PHASE2","title":"PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection","status":"COMPLETED","sponsor":"Queen's Medical Center","startDate":"2011-08-15","conditions":"Adult Hepatocellular Carcinoma, Localized Resectable Adult Liver Carcinoma","enrollment":64},{"nctId":"NCT02608619","phase":"","title":"Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2015-11","conditions":"Erdheim-Chester Disease, Langerhans Cell Histiocytosis, Histiocytic Disorders","enrollment":3},{"nctId":"NCT03376360","phase":"","title":"Functional Medical Imaging Quantization in Prostate Cancer","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2015-10-01","conditions":"Prostate Cancer","enrollment":61},{"nctId":"NCT02840552","phase":"PHASE3","title":"The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer","status":"COMPLETED","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2016-09","conditions":"Prostate Cancer","enrollment":60},{"nctId":"NCT03623425","phase":"PHASE3","title":"Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer","status":"UNKNOWN","sponsor":"Central Hospital, Nancy, France","startDate":"2019-02-01","conditions":"Prostate Cancer","enrollment":46},{"nctId":"NCT01804231","phase":"NA","title":"Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2013-07-09","conditions":"Prostate Cancer","enrollment":22},{"nctId":"NCT00628940","phase":"PHASE1","title":"PET Imaging of High-grade Glioma Using 18F-fluoromethylcholine: a Tool for the Early Detection of Tumour Recurrence After Combined Radiochemotherapy?","status":"COMPLETED","sponsor":"University Ghent","startDate":"2010-01-12","conditions":"High-grade Glioma of the Brain","enrollment":90},{"nctId":"NCT03344822","phase":"PHASE2, PHASE3","title":"Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients","status":"UNKNOWN","sponsor":"Central Hospital, Nancy, France","startDate":"2018-01-02","conditions":"Prostate Cancer","enrollment":33},{"nctId":"NCT00928252","phase":"PHASE1, PHASE2","title":"Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer","status":"COMPLETED","sponsor":"Queen's Medical Center","startDate":"2009-06","conditions":"Hormone Refractory Prostate Cancer","enrollment":25},{"nctId":"NCT03203668","phase":"NA","title":"18F-fluorocholine PET/CT Imaging in Hyperparathyroidism","status":"UNKNOWN","sponsor":"University Medical Centre Ljubljana","startDate":"2013-01-01","conditions":"Hyperparathyroidism","enrollment":1000},{"nctId":"NCT02793882","phase":"","title":"Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer","status":"COMPLETED","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2013-09","conditions":"Prostate Cancer","enrollment":218},{"nctId":"NCT01993160","phase":"NA","title":"18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2013-12","conditions":"Prostate Cancer","enrollment":50},{"nctId":"NCT02232685","phase":"NA","title":"Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2014-09","conditions":"Prostate Cancer","enrollment":143},{"nctId":"NCT02151097","phase":"","title":"PRIME - PRostate Imaging for Margin Evaluation","status":"COMPLETED","sponsor":"Lightpoint Medical Limited","startDate":"2014-11","conditions":"Prostatic Neoplasms","enrollment":7},{"nctId":"NCT01956409","phase":"PHASE4","title":"Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2012-09","conditions":"Breast Cancer Diagnosis, Positron Emission Tomography, Magnetic Resonance Imaging","enrollment":80},{"nctId":"NCT01501630","phase":"","title":"Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2011-12","conditions":"Prostate Cancer","enrollment":112},{"nctId":"NCT02074202","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2014-02","conditions":"Hepatocellular Carcinoma, Liver Disease","enrollment":150},{"nctId":"NCT00670527","phase":"NA","title":"[18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases","status":"UNKNOWN","sponsor":"Odense University Hospital","startDate":"2008-01","conditions":"Prostate Cancer","enrollment":205},{"nctId":"NCT01132599","phase":"PHASE2","title":"Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer","status":"WITHDRAWN","sponsor":"Cancer Research UK","startDate":"2010-05","conditions":"Prostate Cancer","enrollment":""},{"nctId":"NCT01089881","phase":"","title":"The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2008-01","conditions":"Prostate Cancer","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":25,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["fluorine-18 fluoromethylcholine","18F-fluorocholine","18F-choline","FCH"],"phase":"phase_2","status":"active","brandName":"18F-fluoromethylcholine","genericName":"18F-fluoromethylcholine","companyName":"Queen's Medical Center","companyId":"queen-s-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"PET imaging agent for prostate cancer Used for Prostate cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}